PROTHENA CORPORATION PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.16 USD | -0.96% |
|
+8.62% | -36.21% |
| May. 09 | RBC Cuts Price Target on Prothena to $28 From $35, Keeps Sector Perform, Speculative Risk | MT |
| May. 08 | Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $50,000 | MT |
Presenter SpeechTazeen Ahmad (Analysts)Good morning, everybody. Thanks for joining us at the B...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Prothena Corporation plc is an Ireland-based late-stage clinical biotechnology company. The Company is engaged in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid diseases. The Company is advancing a pipeline of therapeutic candidates for a range of indications and targets to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins. The Companyâs pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases, including AL amyloidosis, ATTR amyloidosis, Alzheimerâs disease, Parkinsonâs disease and a range of other neurodegenerative diseases. Its clinical programs include birtamimab for the potential treatment of AL amyloidosis, prasinezumab for the potential treatment of Parkinsonâs disease, NNC6019/PRX004 for the potential treatment of ATTR amyloidosis, and PRX005 and PRX012 for the potential treatment of Alzheimerâs disease.
Calendar
2024-08-06
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
23.39
USD
Average target price
63.43
USD
Spread / Average Target
+171.20%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -36.21% | 1.26B | |
| +8.77% | 114B | |
| +11.17% | 104B | |
| -12.75% | 22.41B | |
| -1.05% | 22.28B | |
| -5.29% | 19.07B | |
| -38.29% | 18B | |
| -4.64% | 17.89B | |
| +7.79% | 14.28B | |
| +35.95% | 12.55B |
- Stock Market
- Equities
- PRTA Stock
- News Prothena Corporation plc
- Transcript : Prothena Corporation plc Presents at Bank of America Securities 2023 Healthcare Conference, May-09-2023 09